Genetic testing experiences for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how patients and doctors feel about genetic testing for prostate cancer. It aims to improve how genetic risk information is shared and understood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were assigned male at birth and are 18 or older.
- You have had genetic testing for prostate cancer and received your results.
- You are from any background, including different ages, ethnicities, or risk levels.
- You are a healthcare provider who has given genetic test results for prostate cancer.
- You are able to give your own consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This study looks at how prostate cancer diagnoses and treatments turn out over time. It compares men who carry rare inherited gene changes that raise prostate cancer risk with men who do not, to better understand which treatments and outcomes may differ.
This study tests a new tool to help Black or African American men with prostate cancer understand genetic testing options. The goal is to improve counseling and decision-making about tumor genetic testing.
This study aims to understand how to better support people from underserved groups, such as Black African and Caribbean men, transgender and non-binary people with a prostate, and those with limited access to healthcare, in using genetic services for prostate cancer. By participating in interviews or focus groups, you can help shape more inclusive and accessible care.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.